Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Procuritas Capital Investors VI on its acquisition of Polarn O. Pyret AB
Mandate

Vinge advises Procuritas Capital Investors VI on its acquisition of Polarn O. Pyret AB

March 11, 2021 Employment and Benefits Banking and Finance Commercial Agreements Corporate Crime & Compliance Intellectual Property EU, Competition and Regulatory M&A IT, Telecommunications and Outsourcing

The clothing company Polarn O. Pyret AB is acquired by Procuritas Capital Investors IV from RNB Retail and Brands AB (publ) at a preliminary purchase price of SEK 330 million on a cash and debt-free basis.

Polarn O. Pyret is a Swedish brand for baby and childrenswear that started in 1976 with the goal of making clothes that let kids be kids. Polarn O. Pyret is a leading brand for high-quality kids wear in the Nordics, and their products are sold in several markets around the world.

The transaction is subject to approval by seller’s bondholders and the Swedish Competition Authority.

Vinge’s team consisted of Jonas Johansson together with, among others, Stina Bengtsson and Mikaela Falkner (M&A), Karolina Cohrs (Real estate), Linn Adelwald and Ludvig Wettergren (Banking and Finance), Sara Strandberg and Emil Lindwall (Employment), Christoffer Nordin (Commercial Agreements), Sofia Bergenstråhle (IP), Agnes Perbo (IT), Tove Lövgren Frisk (Compliance), Johan Wahlbom (Competition law) and VDR-specialist Viktoria Owetz Leyva.

 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025